Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2023, Vol. 55 ›› Issue (5): 871-875. doi: 10.19723/j.issn.1671-167X.2023.05.015

Previous Articles     Next Articles

Choice of medical treatment for renal colic: A survey of Chinese urologists

Ming-rui WANG,Jia-xiang JI,Jin-hui LAI,Xin-wei TANG,Hao-pu HU,Qi WANG,Ke-xin XU,Tao XU,Hao HU*()   

  1. Department of Urology, Peking University People's Hospital, Beijng 100044, China
  • Received:2023-03-20 Online:2023-10-18 Published:2023-10-09
  • Contact: Hao HU E-mail:huhao@bjmu.edu.cn

RICH HTML

   

PDF (PC)

Abstract:

Objective: To investigate the status quo of recognition and management of renal colic among urological surgeons in China. Methods: From November 2021 to March 2022, 725 urological surgeons in China were surveyed in the form of a questionnaire, including their province, hospital grade, professional title, the number of patients with renal colic treated per week, the preferred drugs and the cognition of the disease. This study was approved by the Medical Ethics Committee of Peking University People's Hospital, and all respondents completed informed consent online. Results: During November 2021 and March 2022, urological surgeons across China were surveyed in the form of a questionnaire, and the reliability and validity of the questionnaire were verified before the study was carried out. In the study, 720 valid questionnaires were collected (accounting for 99.31% of the total number), in which 42.4% of the doctors' preferred drugs were non-steroidal anti-inflammatory drugs (NSAIDs), and 40.0% of the doctors' preferred antispasmodic drugs. Opioids were the first choice of 11.0% of the physicians and other treatments were preferred by 6.6% of physicians. In addition, 61.1% of the doctors thought that the mechanism of renal colic was elevated prostaglandin, 32.2% thought it was ureteral spasm, 5.0% thought it was calculi irritation, and 1.7% thought the mechanism was unclear. The doctor of the cognition of the generation mechanism of renal colic pain had a significant influence on the preferred treatment option (χ2=54.399, P < 0.001) that the "elevated prostaglandins" doctor more often preferred NSAIDs than the doctor who thought cramps and ureter stones caused renal colic (51.6% vs. 28.0%, χ2=34.356, P < 0.001;51.6% vs. 19.4%, χ2=13.759, P < 0.001). In addition, hospital class, physician title, and the number of weekly consultations by physicians influenced the choice of medications for renal colic (P < 0.05), tertiary hospitals, middle and senior professional titles and weekly patients with renal colic > 8 cases generally preferred NSAIDs. Conclusion: There are deficiencies in the cognition and drug treatment of renal colic among urological surgeons in China. The choice of the preferred drug was related to the doctor's cognition of the disease, the grade of the hospital, the doctor's professional title and the weekly treatment volume.

Key words: Renal colic, Drug treatment, Status survey

CLC Number: 

  • R692.2

Table 1

First-line drugs in each group of mechanism of renal colic"

First-line drugs Elevated PGs (n=440) Ureteral spasm (n=232) Stone stimulation (n=36) Not aware (n=12)
NSAIDs, n (%) 227 (51.6) 65 (28.0) 7 (19.4) 6 (50.0)
Opioids, n (%) 42 (9.5) 29 (12.5) 5 (13.9) 3 (25.0)
Antispasmodics, n (%) 142 (32.3) 125 (53.9) 18 (50.0) 3 (25.0)
Other drugs, n (%) 29 (6.6) 13 (5.6) 6 (16.7) 0

Table 2

First-line drugs of renal colic in each group of hospital grading"

First-line drugs Grade Ⅰ and Ⅱ (n=165) Grade Ⅲ (n=555)
NSAIDs, n (%) 52 (31.5) 253 (45.6)
Opioids, n (%) 26 (15.8) 53 (9.6)
Antispasmodics, n (%) 72 (43.6) 216 (38.9)
Other drugs, n (%) 15 (9.1) 33 (5.9)

Table 3

First-line drugs in each group of ranks of urologists"

First-line drugs Resident (n=134) Attending (n=304) Associate professor (n=199) Professor (n=83)
NSAIDs, n (%) 46 (34.3) 120 (39.5) 102 (51.3) 37 (44.6)
Opioids, n (%) 11 (8.2) 41 (13.5) 16 (8.0) 11 (13.3)
Antispasmodics, n (%) 73 (54.5) 119 (39.1) 73 (36.7) 23 (27.7)
Other drugs, n (%) 4 (3.0) 24 (7.9) 8 (4.0) 12 (14.5)

Table 4

First-line drugs in each group of the number of renal colic cases per week"

First-line drugs ≤8 cases/week (n=367) ＞8 cases/week (n=352)
NSAIDs, n (%) 138 (37.6) 166 (47.2)
Opioids, n (%) 49 (13.4) 30 (8.5)
Antispasmodics, n (%) 155 (42.2) 133 (37.8)
Other drugs, n (%) 25 (6.8) 23 (6.5)
1 Ayan M , Sogut E , Tas U , et al. Pain levels associated with renal colic and primary dysmenorrhea: A prospective controlled study with objective and subjective outcomes[J]. Arch Gynecol Obstet, 2012, 286 (2): 403- 409.
doi: 10.1007/s00404-012-2316-4
2 米华, 邓耀良. 中国尿石症的流行病学特征[J]. 中华泌尿外科杂志, 2003, 24 (10): 715- 716.
3 曾国华, 麦赞林, 夏术阶, 等. 中国成年人群尿石症患病率横断面调查[J]. 中华泌尿外科杂志, 2015, 36 (7): 528- 532.
doi: 10.3760/cma.j.issn.1000-6702.2015.07.014
4 Steinberg PL , Chang SL . Pain relief for acute urolithiasis: The case for non-steroidal anti-inflammatory drugs[J]. Drugs, 2016, 76 (10): 993- 997.
doi: 10.1007/s40265-016-0595-y
5 Perlmutter A , Miller L , Trimble LA , et al. Toradol, an NSAID used for renal colic, decreases renal perfusion and ureteral pressure in a canine model of unilateral ureteral obstruction[J]. J Urol, 1993, 149 (4): 926- 930.
doi: 10.1016/S0022-5347(17)36261-4
6 Davenport K , Waine E . The role of non-steroidal anti-inflammatory drugs in renal colic[J]. Pharmaceuticals (Basel), 2010, 3 (5): 1304- 1310.
doi: 10.3390/ph3051304
7 黄健. 中国泌尿外科和男科疾病诊断治疗指南(2019版)[M]. 北京: 科学出版社, 2020: 237- 267.
8 Turk C , Petrik A , Sarica K , et al. EAU guidelines on diagnosis and conservative management of urolithiasis[J]. Eur Urol, 2016, 69 (3): 468- 474.
doi: 10.1016/j.eururo.2015.07.040
9 宁本翔, 孙西钊, 周乐卿, 等. 上尿路结石导致肾绞痛的急诊处理: 南京地区现况调查[J]. 中华泌尿外科杂志, 2014, 35 (2): 95- 97.
10 Lasoye TA , Sedgwick PM , Patel N , et al. Management of acute renal colic in the UK: A questionnaire survey[J]. BMC Emerg Med, 2004, 4 (1): 5.
doi: 10.1186/1471-227X-4-5
11 Bounes V , Valle B , Concina F , et al. Treatment of acute renal colic in US and French EDs: Simulated cases and real cases in acute pain management[J]. Am J Emerg Med, 2016, 34 (10): 1955- 1958.
doi: 10.1016/j.ajem.2016.06.107
12 Pathan SA , Mitra B , Cameron PA . A systematic review and meta-analysis comparing the efficacy of nonsteroidal anti-inflammatory drugs, opioids, and paracetamol in the treatment of acute renal colic[J]. Eur Urol, 2018, 73 (4): 583- 595.
doi: 10.1016/j.eururo.2017.11.001
13 Afshar K , Jafari S , Marks AJ , et al. Nonsteroidal anti-inflammatory drugs (NSAIDs) and non-opioids for acute renal colic[J]. Cochrane Database Syst Rev, 2015, 29 (6): CD006027.
14 Gu HY , Luo J , Wu JY , et al. Increasing nonsteroidal anti-inflammatory drugs and reducing opioids or paracetamol in the management of acute renal colic: Based on three-stage study design of network meta-analysis of randomized controlled trials[J]. Front Pharmacol, 2019, 22 (10): 96.
15 Papadopoulos G , Bourdoumis A , Kachrilas S , et al. Hyoscine N-butylbromide (Buscopan®) in the treatment of acute ureteral colic: What is the evidence?[J]. Urol Int, 2014, 92 (3): 253- 257.
doi: 10.1159/000358015
16 Tomiak RH , Barlow RB , Smith PJ . Are there valid reasons for using anti-muscarinic drugs in the management of renal colic?[J]. Br J Urol, 1985, 57 (5): 498- 499.
doi: 10.1111/j.1464-410X.1985.tb05854.x
17 Holdgate A , Oh CM . Is there a role for antimuscarinics in renal colic? A randomized controlled trial[J]. J Urol, 2005, 174 (2): 572- 575.
doi: 10.1097/01.ju.0000165337.37317.4c
18 Gurbuz MC , Polat H , Canat L , et al. Efficacy of three different alpha 1-adrenergic blockers and hyoscine N-butylbromide for distal ureteral stones[J]. Int Braz J Urol, 2011, 37 (2): 195- 200.
doi: 10.1590/S1677-55382011000200006
19 Lu Z , Dong Z , Ding H , et al. Tamsulosin for ureteral stones: A systematic review and meta-analysis of a randomized controlled trial[J]. Urol Int, 2012, 89 (1): 107- 115.
doi: 10.1159/000338909
20 Meltzer AC , Burrows PK , Wolfson AB , et al. Effect of tamsulosin on passage of symptomatic ureteral stones: A randomized clinical trial[J]. JAMA Intern Med, 2018, 178 (8): 1051- 1057.
21 Law YXT , Teoh JYC , Castellani D , et al. Role of pre-operative ureteral stent on outcomes of retrograde intra-renal surgery (RIRS): Systematic review and meta-analysis of 3 831 patients and comparison of Asian and non-Asian cohorts[J]. World J Urol, 2022, 40 (6): 1377- 1389.
[1] Mingrui WANG, Qi WANG, Hao HU, Jinhui LAI, Xinwei TANG, Chunyan WAN, Kexin XU, Tao XU. Efficacy of coated metal ureteral stent in the treatment of pelvic lipomatosis induced hydronephrosis [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 919-922.
[2] Zhi-gang ZHANG,Xin-min LIU. Clinical characteristics of patients with acute renal infarction: an analysis of 52 patients in a single center [J]. Journal of Peking University(Health Sciences), 2019, 51(5): 863-869.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd